Charles Michael Schwach

DDS | Dentist



  
  5432 Broadway St, Lancaster
  New York, 14086-2124

  716-683-7313    716-683-7358 Maps & Directions
Charles Michael Schwach is a Lancaster, New York based Dentist who is specialized in Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 5432 Broadway St, Lancaster. Patients can reach him at 716-683-7313.
Charles Michael Schwach is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Charles Michael Schwach speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Charles Michael Schwach
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:5432 Broadway St, Lancaster,
New York, 14086-2124
Phone:716-683-7313
Fax:716-683-7358
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 3072813831
Enrollment ID: I20151130001281
NPI Number: 1821284324
NPI Enumeration Date: 18 Sep, 2007
NPI Last Update On: 20 Jan, 2011

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 5432 Broadway St,
Lancaster, New York
Zip: 14086-2124
Phone Number: 716-683-7313
Patients can reach Charles Michael Schwach at 5432 Broadway St, Lancaster, New York or can call to book an appointment on 716-683-7313. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: